A Study of the Efficacy and Safety of MK-4618 in Patients with Overactive Bladder (OAB)

Mise à jour : Il y a 4 ans
Référence : EUCTR2011-002533-18

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

1. To assess the long-term safety and tolerability of treatment with MK-4618 compared to tolterodine ER. 2. To assess the long-term safety profile of MK-4618 dosed concomitantly with tolterodine ER, relative to MK-4618 monotherapy and/or tolterodine ER monotherapy.


Critère d'inclusion

  • Overactive Bladder